Trial intelligence / Profile preview

Acute colchicine effects on neutrophil function in coronary artery disease

ACTRN12619001005145Phase 2Not yet recruiting

Sponsor
A/Prof Sanjay Patel
Start
Jul 2019
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of colchicine in coronary arteriosclerosis, acute coronary syndrome (ACS), angina pectoris, sponsored by A/Prof Sanjay Patel. Planned start Jul 2019; status: not yet recruiting.

02

Drugs

colchicine
03

Conditions

coronary arteriosclerosisacute coronary syndrome (ACS)angina pectoris

Beyond the preview

Go deeper on ACTRN12619001005145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12619001005145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call